CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn

CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn

South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...

CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn

CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn

CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner